Eureka projects

Based on cannabis metabolomics, cannabis smoke-analysis and advanced extraction techniques, tailor-made well-defined extractions will be made for different medical applications and new techniques for oral admin will be developed.
Project ID: 

Personalised medicine has been targeted as the most important future development in both medicine and drug development. The final product that synergistically combines the two companies' capabilities will be a software platform.
Project ID: 

We will explore a novel type of cavvine against food allergy by designing a vaccine with an antibody-like structure using recombinant allergen and a targeting unit. Canditate molecules will be tested in-vitro and in an animal model.
Project ID: 

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.